ASH® 20 Annual Meeting Review


Virtual dates:

Saturday, December 12th, 2020

Saturday, December 19th, 2020

No Registration Fee for Healthcare Providers

Target Audience

  • Hematologists/Oncologists
  • Pharmacists
  • Nurses
  • Nurse Practitioners and Physician Assistants
  • Residents and Fellows
  • Researchers and others involved in the management of patients with blood disorders and hematologic malignancies

Learning Objectives

At the conclusion of the activity, participants will be able to:

  • Discuss new and updated treatment options for patients with blood disorders and hematologic malignancies 
  • Identify side effects, indications, and contra-indications of various therapies used to diagnose and treat blood disorders and hematologic malignancies, and explain how to effectively manage those side-effects
  • Summarize diagnostic and treatment-related data relevant to multidisciplinary care
  • Review data presented at the 62nd ASH Annual Meeting (2020) and discuss their application in clinical settings

CME Credit Statement

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 6 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Continuing Education Credits – Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.

How to claim your CME or CE credits:

If you participated in this CME activity either 12/12/20 or 12/19/20, you should have received an email from the program chairs for each day about completing the post-activity evaluation. Please complete the evaluation by 12/31/20 to claim your credits. If you did not receive the evaluation for one or both days, please email – [email protected].

Commercial Support Acknowledgement

This activity has been supported by independent medical education grant from the following organizations:

  • Dova Pharmaceuticals
  • Bristol Myers Squibb
  • Jazz Pharmaceuticals

Featured Faculty

Dr. Shaji Kumar

Mayo School of Medicine

Dr. Doris Quon

Orthopedic Hemophilia Treatment Center

Dr. Andrew Cowan

University of Washington

Disclosure of Off-label product

This educational activity may or may not contain discussions of investigational, unapproved, or off-label products. Participants should consult prescribing information for products discussed during these meetings. Faculties will disclose at the time of presentation if any off-level product being discussed.

Disclosure of Conflict of Interest

The Binaytara Foundation collects disclosure information from all faculty and organizing committee members involved in planning, implementation, and evaluation of our continuing medical education activities. All conflict will be identified and resolved for everyone in control of the contents of this activity before their participation in this educational activity.

No member of the activity planning committee has any relevant financial relationship with an ACCME defined commercial interest.

Faculty disclosure of relevant financial relationship will be provided to participants during the meeting. Participants can also request a copy of the faculty disclosure ahead of time once the information about Continuing Medical Education Credits is made available. Please contact [email protected] to request the disclosures.

Registration is now open. Please click here to navigate to our registration page.